Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - GENVEC INCv373028_ex99-1.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 28, 2014

 

 

 

GenVec, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

(state or other jurisdiction of

incorporation)

0-24469

(Commission

File Number)

23-2705690

(I.R.S. Employer

Identification No.)

 

910 Clopper Road

Suite 220N

Gaithersburg, Maryland

20878

(Zip Code)

(Address of principal executive offices)  

 

Registrant's telephone number, including area code: (240) 632-0740

 

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
 

 

INFORMATION TO BE INCLUDED IN THE REPORT

 

Section 2 – Financial Information

 

Item 2.02 Results of Operations and Financial Condition.

 

On March 28, 2014, GenVec, Inc. (“GenVec”) issued a press release announcing its financial results for the quarter and year ended December 31, 2013.

 

A copy of GenVec’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Section 9 – Financial Statements and Exhibits

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
     
99.1   GenVec, Inc. press release dated March 28, 2014, announcing financial results for the quarter and year ended December 31, 2013.  

 

2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  GENVEC, INC.
   
  By: /s/ Douglas J. Swirsky
    Douglas J. Swirsky
    President, Chief Executive Officer, Chief
    Financial Officer, Treasurer and Corporate Secretary

 

Dated: March 28, 2014

 

3
 

 

EXHIBIT INDEX

Exhibit No.   Description
     
99.1   GenVec, Inc. press release dated March 28, 2014, announcing financial results for the quarter and year ended December 31, 2013.  

 

4